The U.S. Food & Drug Administration (FDA) has issued a warning stating that women using Beyaz and other similar drospirenone-containing birth control pills could be at an increased risk of developing life-threatening blood clots. The FDA is currently in the process of investigating potential Beyaz side effects and other drospirenone-induced drug interactions. Signs and symptoms of a blood clot may include swelling, warmth, redness, and pain at the site of the clot.
Beyaz Update 9/11/12: A newly-released study conducted by the U.S. Food & Drug Administration (FDA) found no unexpected evidence of specific pediatric concerns regarding teen use of Bayer’s popular birth control pill Beyaz. The new research is part of the administration’s continuing effort to explore better ways of understanding the increased risk of blood clots associated with Beyaz and other drospirenone-based contraceptives.
Free Beyaz Blood Clot Lawsuit Evaluation: If you or a loved one suffered a blood clot after taking Beyaz, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem with Beyaz?
In September 2011, the FDA issued a press release warning the public that the use of Beyaz and other contraceptives containing drospirenone could potentially be linked to an increased risk of blood clots. The warning came in response to the administration’s review of two independently-conducted studies which analyzed the risk of blood clots in drospirenone birth control users. The research found that women who take these types of contraceptives have approximately 1.5 times the risk of blood clots compared to women who use older forms of birth control.
“All birth control pills pose a risk of blood clots,” the FDA announcement stated. “Several epidemiological studies have reported that the risk of blood clots for women who use birth control pills containing drospirenone is higher than that for women who use birth control pills containing the progestin levonorgestrel. Other studies have not reported an increase in risk.”
What types of blood clots have been linked to Beyaz?
Beyaz and other drospirenone-containing birth control pills have been increasingly linked to the following types of blood clots:
- Deep Vein Thrombosis (DVT) – Occurs when a blood clot forms in a vein deep inside the body (most often in the lower legs or thighs). DVTs become dangerous when they break off and migrate through the bloodstream. Once a clot breaks loose, it is referred to as an embolus. It can travel to an artery in the lungs and block blood flow, resulting in a life-threatening situation known as a pulmonary embolism.
- Pulmonary Embolism (PE) – Once an embolus has broken free and become lodged in one of the branches of the pulmonary artery, the PE clogs the blood supply to the lung, preventing the exchange of oxygen and carbon dioxide. If left untreated, pulmonary embolisms may cause lung tissue to die (infarct).
- Venous Thromboembolism (VTE) – Situation that results when a deep vein thrombosis breaks off and becomes a pulmonary embolism. When a DVT becomes a PE, the condition is collectively referred to as a venous thromboembolism.
Beyaz Side Effects
In addition to having the potential to cause these types of blood clots, Beyaz has been associated with the following serious side effects:
- Heart Attacks
- Cardiac Arrhythmias
- Kidney Failure
- Gallbladder Disease
- Hepatic Adenoma
- Sudden Death
Do I Have a Beyaz Blood Clot Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Beyaz lawsuits. We are handling individual litigation nationwide and currently accepting new blood clot cases in all 50 states.
Free Confidential Case Evaluation: Again, if you developed a blood clot after using Byaz, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and our lawyers can help.